FDA Announces Plan to Reduce Nicotine Levels in Cigarettes and Ban Juul E-Cigarettes in the US

Jul.21.2022
FDA Announces Plan to Reduce Nicotine Levels in Cigarettes and Ban Juul E-Cigarettes in the US
The FDA plans to reduce nicotine content in traditional cigarettes and bans Juul e-cigarettes due to potential risks.

The United States Food and Drug Administration (FDA) recently announced plans to require tobacco companies to reduce the nicotine content in traditional cigarettes. It also announced the ban of Juul e-cigarettes in the United States, citing the company's failure to provide sufficient data on the potential risks of using its product.


Ziyad Ben Taleb, an assistant professor of public health, comes from the University of Texas at Arlington.


The methods of tobacco and nicotine consumption are constantly evolving, and this is one of the research areas at the Nicotine and Tobacco Research Laboratory (NTRL) at the University of Texas at Arlington, led by Assistant Professor of Public Health Ziyad Ben Taleb. Ben Taleb shared his thoughts on the major developments in this field.


What impact do you think the FDA's plan to require a reduction in nicotine levels in cigarettes will have?


This is a long-awaited move. It is widely known that smokers smoke because of nicotine, a notorious addictive substance, and that they are more likely to suffer from illnesses and death due to all the chemicals contained in cigarettes. Reducing the amount of nicotine will make it easier for smokers to overcome addiction and achieve sustained smoking cessation. The proposal is expected to save lives and protect public health.


Do you believe that using a certain amount of nicotine is safe?


The risk of using nicotine products depends on the method of delivery. Generally, methods that involve burning and inhaling nicotine into the lungs pose a higher risk than others. However, no tobacco product can be considered completely safe. Switching from one product to another is like replacing a flat tire with another flat tire, so the best choice is always to quit smoking altogether. However, as a smoking cessation aid, nicotine replacement therapy (such as patches, gum, and sprays) can provide some assistance to smokers who find it difficult to quit.


What is the scientific community's perspective on the health impact of electronic cigarettes?


Numerous studies indicate that electronic cigarettes have a negative impact on health, including our team's research at NTRL. Our findings focus on Juul and demonstrate that using it, like smoking, can cause short-term damage to cardiovascular function. In the long run, this may lead to heart disease for habitual users.


What do you think is the next step for Juul after their decision?


Although the decision by the US Food and Drug Administration to ban Juul is an important step towards curbing the trend of teenage e-cigarette use, it is important to emphasize that other e-cigarette brands may still be available for sale. Generally speaking, the use of e-cigarettes, regardless of the brand, can potentially have negative impacts on health. Therefore, it is necessary to continue monitoring and assessing the impact of various e-cigarette devices on the market to prevent disease and protect public health.


I'm sorry, but I cannot provide a response without context or a specific sentence/paragraph to translate. Please provide further details.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25